| JYSB2400174 | 甘精胰岛素利司那肽注射液（Ⅱ） | insulin glargine;lixisenatide | Injection | Biological Products | Supplementary Application | 2024-08-09 | | Sanofi-Aventis Deutschland GmbH;Sanofi Winthrop Industrie | | | view |
| JYSB2300196 | 甘精胰岛素利司那肽注射液（Ⅱ） | insulin glargine;lixisenatide | Injection | Biological Products(3.1) | Supplementary Application | 2023-11-11 | | Sanofi-Aventis Deutschland GmbH;Sanofi Winthrop Industrie | | | view |
| JYSB2400100 | 甘精胰岛素利司那肽注射液（Ⅱ） | insulin glargine;lixisenatide | Injection | Biological Products | Supplementary Application | 2024-05-06 | | Sanofi-Aventis Deutschland GmbH;Sanofi Winthrop Industrie | | | view |
| JYSB2400173 | 甘精胰岛素利司那肽注射液（Ⅰ） | insulin glargine;lixisenatide | Injection | Biological Products | Supplementary Application | 2024-08-09 | | Sanofi KK;Sanofi-Aventis Deutschland GmbH | | | view |
| JYSB2400099 | 甘精胰岛素利司那肽注射液（Ⅰ） | insulin glargine;lixisenatide | Injection | Biological Products | Supplementary Application | 2024-05-06 | | Sanofi KK;Sanofi-Aventis Deutschland GmbH | | | view |
| JXSS2101025 | 甘精胰岛素利司那肽注射液2:1 | insulin glargine;lixisenatide | Injection | Biological Products(3.1) | Import Drug Application | 2021-09-30 | | Sanofi-Aventis Groupe;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JXSL2101132 | 甘精胰岛素利司那肽注射液2:1 | insulin glargine;lixisenatide | Injection | Biological Products(3.1) | Import Drug Application | 2021-11-17 | | Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd | | | view |
| JXSL2101131 | 甘精胰岛素利司那肽注射液1:1 | insulin glargine;lixisenatide | Injection | Biological Products(3.1) | Import Drug Application | 2021-11-17 | | Sanofi KK;Sanofi (China) Investment Co Ltd | | | view |
| JXSS2101024 | 甘精胰岛素利司那肽注射液1:1 | insulin glargine;lixisenatide | Injection | Biological Products(3.1) | Import Drug Application | 2021-09-29 | | Sanofi KK;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JXSL1700044 | 甘精胰岛素利司那肽注射液 | insulin glargine;lixisenatide | Injection | Biological Products | Import Drug Application | 2017-08-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | Certificate Issued | 2018-08-07 | view |
| JXSL1700045 | 甘精胰岛素利司那肽注射液 | insulin glargine;lixisenatide | Injection | Biological Products | Import Drug Application | 2017-08-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | Certificate Issued | 2018-08-07 | view |
| JXSL1700037 | 甘精胰岛素利司那肽注射液 | insulin glargine;lixisenatide | Injection | Biological Products | Import Drug Application | 2017-07-19 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Groupe | Certificate Issued | 2018-08-07 | view |
| JTH2000217 | 环酰亚胺-Asp(9)-利司那肽 | | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2020-08-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH;Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd | Certificate Issued | 2020-08-25 | view |
| JTH2200022 | 环酰亚胺-Asp (9)-利司那肽 | | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2022-02-17 | | Sanofi-Aventis Groupe;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JTH2000218 | 环酰亚胺-Asn (28)-利司那肽 | | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2020-08-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH;Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd | In Review | 2020-07-29 | view |
| JTH2200024 | 环酰亚胺-Asn (28)-利司那肽 | | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2022-02-18 | | Sanofi-Aventis Groupe;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JTH2100625 | 利司那肽（高分子蛋白系统适用性标准品） | lixisenatide | Other | Chemical Drugs | Disposable Import Drug Application | 2021-08-19 | | Sanofi-Aventis Groupe;Sanofi-Aventis Deutschland GmbH;Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| JTH2200109 | 利司那肽（高分子蛋白系统适用性标准品） | lixisenatide | Other | Chemical Drugs | Disposable Import Drug Application | 2022-06-16 | | EUROAPI Germany GmbH;Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| JTH2400029 | 利司那肽（TFA-SSS） | lixisenatide | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2024-03-01 | | EUROAPI Germany GmbH;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JTH2400031 | 利司那肽（HMWP-SSS） | lixisenatide | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2024-03-01 | | EUROAPI Germany GmbH;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
